Showing results (391-400 of 408) with videos related to
Sort By:
Pageof 41
Molecular Therapy. Advances|July 13, 2026
AAV vector production in suspension cells using PEI transfection and sodium butyrate with orthogonal assessment of function and qualitySujan Ravendran, Simon Fammé, Maya Graham Noer, et al.Nature|November 19, 2010
2'-O methylation of the viral mRNA cap evades host restriction by IFIT family membersStephane Daffis, Kristy J Szretter, Jill Schriewer, et al.Sleep Health|April 19, 2023
Associations of bedroom PM2.5, CO2, temperature, humidity, and noise with sleep: An observational actigraphy studyMathias Basner, Michael G Smith, Christopher W Jones, et al.BMC Psychiatry|May 30, 2023
Evaluating a multimodal, clinical and work-directed intervention (RTW-PIA) to support sustainable return to work among employees with mental disorders: study protocol of a multicentre, randomised controlled trialFiona Starke, Alexandra Sikora, Ralf Stegmann, et al.European Urology Open Science|December 12, 2022
Impact of Surgical Experience Before Robot-assisted Partial Nephrectomy on Surgical Outcomes: A Multicenter Analysis of 2500 PatientsNina N Harke, Markus A Kuczyk, Stephan Huusmann, et al.Scientific Reports|October 8, 2016
Hepatic Deletion of Janus Kinase 2 Counteracts Oxidative Stress in MiceMadeleine Themanns, Kristina M Mueller, Sonja M Kessler, et al.The Australasian Journal of Dermatology|December 5, 2025
Efficacy and Safety of Risankizumab in Psoriatic Patients With a History of Malignancy: Real-World Evidence From a Multicentre Spanish StudyJavier Mataix Díaz, Sergio Santos Alarcón, Isabel Belinchón Romero, et al.Minerva Urology and Nephrology|November 28, 2024
Robot-assisted partial nephrectomy of multiple tumors: a multicenter analysisPouriya Faraj Tabrizi, Philip Zeuschner, Olga Katzendorn, et al.Soudni Lekarstvi|February 2, 2011
[The correlation of results of breath analysers and laboratory blood examinations of blood-ethanol concentration (Czech and Slovak study)]M Hirt, T Vojtísek, M Zelený, et al.Cancer Immunology, Immunotherapy : CII|February 17, 2019
A phase I/IIa study of the mRNA-based cancer immunotherapy CV9201 in patients with stage IIIB/IV non-small cell lung cancerMartin Sebastian, Andreas Schröder, Birgit Scheel, et al.Pageof 41